These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17656618)

  • 1. Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib.
    Schwartz JI; Agrawal NG; Kher UA; DeSmet M; Cavanaugh PF; Guillaume M; Ebel DL; Merschman SA; Wagner JA
    J Clin Pharmacol; 2007 Oct; 47(10):1342-6. PubMed ID: 17656618
    [No Abstract]   [Full Text] [Related]  

  • 2. Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.
    Agrawal NG; Porras AG; Matthews CZ; Rose MJ; Woolf EJ; Musser BJ; Dynder AL; Mazina KE; Lasseter KC; Hunt TL; Schwartz JI; McCrea JB; Gottesdiener KM
    J Clin Pharmacol; 2003 Mar; 43(3):268-76. PubMed ID: 12638395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
    Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
    Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM
    J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antacids on the absorption of simultaneously ingested iron.
    O'Neil-Cutting MA; Crosby WH
    JAMA; 1986 Mar; 255(11):1468-70. PubMed ID: 3005669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid rebound.
    Fordtran JS
    N Engl J Med; 1968 Oct; 279(17):900-5. PubMed ID: 20617595
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients].
    Tympner F
    Fortschr Med; 1985 Sep; 103(33):795-8. PubMed ID: 4054802
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.
    Flor S; Guay DR; Opsahl JA; Tack K; Matzke GR
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2436-8. PubMed ID: 2088202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
    Schwartz JI; Agrawal NG; Wehling M; Musser BJ; Gumbs CP; Michiels N; De Smet M; Wagner JA
    Br J Clin Pharmacol; 2008 Dec; 66(6):811-7. PubMed ID: 18823299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the interactions during storage of compounds of the antacid group. I. Interactions of the components in suspensions].
    Pawlaczyk J; Lutka A
    Acta Pol Pharm; 1989; 46(1):74-80. PubMed ID: 2816464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium hydroxide/aluminium hydroxide-containing antacid does not affect the pharmacokinetics of the targeted phosphodiesterase 4 inhibitor roflumilast.
    Nassr N; Lahu G; Hünnemeyer A; von Richter O; Knoerzer D; Reutter F; Zech K; Hermann R
    J Clin Pharmacol; 2007 May; 47(5):660-6. PubMed ID: 17374735
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
    Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between ciprofloxacin and antacids--dissolution and adsorption studies.
    Arayne MS; Sultana N; Hussain F
    Drug Metabol Drug Interact; 2005; 21(2):117-29. PubMed ID: 16355977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F
    Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of etoricoxib: other considerations.
    Kim JA; Choi YS; Kim SH
    Mayo Clin Proc; 2005 Sep; 80(9):1233-4; author reply 1234. PubMed ID: 16178505
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
    Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
    Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.